000141401 001__ 141401
000141401 005__ 20240229112524.0
000141401 0247_ $$2doi$$a10.1038/s41375-018-0195-9
000141401 0247_ $$2pmid$$apmid:29959413
000141401 0247_ $$2ISSN$$a0887-6924
000141401 0247_ $$2ISSN$$a1476-5551
000141401 0247_ $$2altmetric$$aaltmetric:44324965
000141401 037__ $$aDKFZ-2018-01907
000141401 041__ $$aeng
000141401 082__ $$a610
000141401 1001_ $$00000-0002-6226-1252$$aMai, Elias K$$b0
000141401 245__ $$aBortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma.
000141401 260__ $$aLondon$$bSpringer Nature$$c2019
000141401 3367_ $$2DRIVER$$aarticle
000141401 3367_ $$2DataCite$$aOutput Types/Journal article
000141401 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1550215815_21966
000141401 3367_ $$2BibTeX$$aARTICLE
000141401 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141401 3367_ $$00$$2EndNote$$aJournal Article
000141401 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000141401 588__ $$aDataset connected to CrossRef, PubMed,
000141401 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b1$$udkfz
000141401 7001_ $$aBertsch, Uta$$b2
000141401 7001_ $$aSchlenzka, Jana$$b3
000141401 7001_ $$aSalwender, Hans J$$b4
000141401 7001_ $$aMunder, Markus$$b5
000141401 7001_ $$aGerecke, Christian$$b6
000141401 7001_ $$aDührsen, Ulrich$$b7
000141401 7001_ $$aBrossart, Peter$$b8
000141401 7001_ $$aNeben, Kai$$b9
000141401 7001_ $$aHillengass, Jens$$b10
000141401 7001_ $$aRaab, Marc S$$b11
000141401 7001_ $$aMerz, Maximilian$$b12
000141401 7001_ $$aBaertsch, Marc-Andrea$$b13
000141401 7001_ $$aJauch, Anna$$b14
000141401 7001_ $$aHose, Dirk$$b15
000141401 7001_ $$aMartin, Hans$$b16
000141401 7001_ $$aLindemann, Hans-Walter$$b17
000141401 7001_ $$aBlau, Igor W$$b18
000141401 7001_ $$aScheid, Christof$$b19
000141401 7001_ $$aWeisel, Katja C$$b20
000141401 7001_ $$aGoldschmidt, Hartmut$$b21
000141401 7001_ $$aGroup, German-speaking Myeloma Multicenter$$b22$$eCollaboration Author
000141401 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-018-0195-9$$n1$$p258-261$$tLeukemia$$v33$$x1476-5551$$y2019
000141401 909CO $$ooai:inrepo02.dkfz.de:141401$$pVDB
000141401 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000141401 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000141401 9141_ $$y2019
000141401 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141401 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141401 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2017
000141401 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141401 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000141401 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000141401 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141401 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000141401 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141401 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141401 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000141401 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000141401 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2017
000141401 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000141401 980__ $$ajournal
000141401 980__ $$aVDB
000141401 980__ $$aI:(DE-He78)C060-20160331
000141401 980__ $$aUNRESTRICTED